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INTRODUCTION
Research on abnormal behavior in small animals,
and especially in dogs (Cyranoski, 2010), has become
increasingly important in the last couple decades due
to the growing public interest in companion animals,
which parallels the increasing demand for more fun-
damental veterinary health care. This has paved the
way to introducing new tools such as functional ima-
ging modalities in canine behavioral medicine, in ad-
dition to the standard diagnostic tools such as anam-
nesis, behavioral consultation, blood work, behavioral
questionnaires and structural imaging modalities. The
functional imaging modalities of Single Photon Emis-
sion Computed Tomography (SPECT) and Positron
Emission Tomography (PET), which have recently en-
tered the scene of veterinary behavioral medicine, of-
fer the possibility to demonstrate relationships between
disturbances in certain brain regions and neurotrans-
mitter systems and certain behavior disturbances (Pe-
remans et al., 2003a; Vermeire et al., 2010; Irimajiri et
al., 2010). Research focusing on physiological brain
alterations leads to insights into the pathophysiology of
the disease, thus enabling correct diagnosis and treat-
ment. 
This manuscript aims to give a brief overview of the
available functional imaging techniques and to review
present research findings in human and animal anxiety
disorders based on functional brain imaging modalities. 
Functional brain imaging modalities
The available functional imaging modalities are
not invasive, yet they are in vivo techniques that can
look beyond the structural abnormalities and detect dis-
turbances at the neuron level by imaging brain systems
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When used in combination with specific radioactive markers, functional imaging modalities such as Single
Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) enable the
visualization of several neurotransmitter receptors and transporters, as well as of the perfusion and
metabolism of the brain. 
This paper gives an overview of the functional imaging techniques, as well as of the studies that have been
performed on humans and canines with anxiety disorders. Thus far, most of the research in this field has been
focused on brain perfusion and the serotonergic and dopaminergic neurotransmitters, and less on gamma-
aminobutyric acid (GABA), glutamate, norepinephrine and the hypothalamic-pituitary-adrenal (HPA) axis.  
SAMENVATTING
Aan de hand van functionele beeldvormingstechnieken, zoals Single Photon Emission Computed Tomography
(SPECT) en Positron Emission Tomography (PET), en de bijpassende radioactieve merkers kunnen receptoren en
transporters van neurotransmittersystemen in beeld gebracht worden. Ook de hersenperfusie en het hersenmeta-
bolisme kunnen met diezelfde modaliteiten bepaald worden.
In dit artikel worden de technische specificaties van de verschillende beeldvormingsmodaliteiten kort aangekaart.
In tweede instantie worden de functionele beedvormingsstudies die handelen over angststoornissen bij mens en hond,
besproken. Hierbij wordt voornamelijk over hersenperfusie en het serotonerge en dopaminerge systeem gerapporteerd
en minder over gamma-aminobutyraat (GABA), glutamaat, norepinefrine en de hypothalamische-hypofysaire
bijnieras (HPA). 
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such as the neurotransmitter systems, cerebral blood
flow and brain glucose metabolism.
The three main neuroimaging modalities are briefly
explained below.
Single Photon Emission Computed Tomography
(SPECT)
After intravenous injection of a gamma ray (photon)
emitting radiopharmaceutical, SPECT cameras can re-
gister the distribution of these photons within the pa-
tient. This tomographic nuclear imaging modality con-
sists of gamma ray detectors which rotate around the
patient’s axis. Each detector consists of a collimator, a
sodium iodine crystal and photomultiplier tubes (Clif-
ford and Daniel, 2006). Collimators, which are made
of lead and exist in different shapes and thicknesses, al-
low only photons coming from a specific direction to
enter the crystal. Photons not coming from the speci-
fic direction are absorbed by the collimator and con-
sequently do not reach the crystal. The crystal is a
crucial part of the apparatus, as it registers the photons
and converts them into light signals. Finally, the photo-
multiplier tubes convert the light signals into a mea-
surable electric current which, after reconstruction, re-
sults in a 3-dimensional image that can be viewed as
multiple 2-dimensional images in the 3 spatial planes
(horizontal, transversal and sagittal) (Figure 1). 
99mTechnetium (99mTc) is the most often used isotope
in SPECT imaging (Kowalsky, 2006). The short half-
life (6 hours), the emission of only gamma rays, the
gamma ray energy of 142 keV, the  availability of
ready-to-use pharmaceutical kits and the easy access to
it (through the Molybdeen generator) makes 99mTc the
ideal radionuclide for SPECT imaging. In Table 1 the
commercially available radiopharmaceuticals for brain
single photon emission computed tomography and po-
sitron emission tomography are presented, as well as
the advantages and disadvantages of both techniques.
As can be seen in Table 1, radiopharmaceuticals sys-
tematically have two compounds: a chemical substance
(e.g. ethyl cysteinate dimer (ECD) or fluorodeoxyglu-
cose (FDG)) which directs the radiopharmaceutical to
a certain target, and a radioactive marker (e.g. 99mTc or
18F) which enables the radiopharmaceutical to be
imaged. For instance, labeling the chemical substance
FDG with the radioactive marker 18F enables the ana-
lysis of the glucose metabolism in the regions of inte-
rest.  
99mTc-ethyl cysteinate dimer (ECD; Neurolite,
Bristol-Myers Squibb) is an example of a SPECT
tracer used to assess the regional cerebral blood flow
(rCBF) in vivo (Leveille, 1992). This lipophilic radio-
pharmaceutical undergoes rapid uptake in the brain
(i.e. within the first minutes after intravenous injec-
tion) through the blood-brain barrier by transcellular
lipophilic diffusion. Once intracellular, it is trapped
within the brain (by de-esterification into a hydro-
philic compound) in local concentrations proportional
to the local cerebral blood flow (Leonard et al., 1986),
and this brain distribution remains stable for at least
two hours (Leveille et al., 1992). Since the rCBF is
closely linked to the regional brain metabolism and re-
gional neural activity (i.e. in the event of an increase
in brain activity, a higher oxygen and metabolite sup-
ply is required, which is provided for by increased per-
fusion), imaging of the rCBF using SPECT 99mTc-
ECD makes it possible to study the regional neuronal
function (Warwick, 2004).
Positron Emission Tomography (PET)
Positron emission tomography is also a tomogra-
phic nuclear imaging technique, but it uses positron
emitting radiopharmaceuticals.  PET imaging is based
on the positron-electron annihilation reaction, which in-
duces the production of two 511keV gamma rays tra-
veling in opposite directions (Matwichuk-Bassett and
Berry, 2006). It is only when two gamma rays are thus
detected traveling simultaneously in opposite directions
that an event is registered. The use of such a coinci-
dence registration method makes collimation super-
fluous, thereby increasing the sensitivity of PET over
SPECT. Due to the unknown distance the positron will
travel before the positron-electron annihilation occurs,
i.e. the so-called positron range, the precise origin of
the radiopharmaceutical cannot be localized with con-
ventional PET cameras (Figure 2). However, even ta-
king this intrinsic limitation into account, PET spatial
resolution (3-4mm) remains better than that obtained
with conventional SPECT systems (7-9mm) (Rahmin
and Zaidi, 2008). The high cost and the need for a
nearby cyclotron due to the very short half-life of PET
isotopes are the main disadvantages (Table 1). 
Functional Magnetic Resonance Imaging (fMRI)
Functional magnetic resonance imaging is a very
recent functional imaging modality that is based on the
blood oxygenation level and concurrent changes in
magnetic signals that are observed while the patient is
presented with a stimulus or is required to perform a spe-
cific task (Malhi and Lagopoulos, 2008). Hemoglobin
can occur either in an oxygenated or in a deoxygenated
Figure 1. A canine brain is displayed in the 3 spatial
planes (horizontal, sagittal and transverse). 
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state in the blood, with the two states having different
magnetic properties. Because it is known that changes
in neuronal activity result in changes in blood oxyge-
nation, the blood oxygenation level dependent (BOLD)
signal changes visualized by fMRI can be used to assess
neuronal activity. The main advantages of fMRI are
that no radioactive or other contrast agents are required,
and that concurrent high resolution structural MRI
images can be obtained. The price and the applicability,
which is limited to activation studies, are the primary di-
sadvantages. The introduction into veterinary medicine
is impracticable due to the anesthesia required to im-
mobilize the animal, which hinders any task perfor-
mances or measurements of reactions on the stimuli
presented. Therefore, this technique is beyond the scope
of this article. The reader is referred to a review by Di
Salle et al. for more detailed information regarding
fMRI (Di Salle et al., 1999).
Functional imaging of anxiety disorders
Major developments in the field of neuroimaging in
the last decades have created opportunities to investi-
gate neurocircuitry models of anxiety disorders in or-
der to acquire crucial information for the understanding
of these disorders and to investigate the pharmacolo-
gical effects of drugs on them (Kent and Rauch, 2003).
Functional brain imaging techniques like positron
Figure 2. Depicting PET and SPECT.
Table 1. Main radiopharmaceuticals for SPECT and PET, and the advantages and disadvantages of both functional ima-
ging modalities (Peremans et al., 2003b, Rahmim and Zaidi, 2008, Waelbers et al., 2010).
SPECT PET
Isotope T1/2 Isotope T1/2
99mTc 6.0h 15O 2.05 min
123I 13.3h 18F 109.8 min
11C 20.4 min
13N 9.98 min
Radiopharmaceuticals Target Radiopharmaceuticals Target
99mTc-ECD rCBF 15O-H2O rCBF
99mTc-HMPAO rCBF 18F-FDG glucose metabolism
123I-FP-CIT DA transporters 18F-DOPA DA receptors
123I-beta-CIT 5-HT & DA transporters 11C-raclopride DA D2 receptors
Advantages Disadvantages Advantages Disadvantages
relatively low cost limited spatial resolution good spatial resolution expensive
long  T1/2 of isotopes only semi-quantification absolute quantification short T1/2 of isotopes
99Mo generator on site moderate sensitivity high sensitivity need of nearby cyclotron
easy tracer labeling complex tracer labeling
T1/2: half life;  rCBF: regional cerebral blood flow; 5-HT: serotonin; DA: dopamine
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emission tomography (PET), single photon emission
computed tomography (SPECT) and functional mag-
netic resonance imaging (fMRI) can be used to study
the relationships between cerebral blood flow, cerebral
metabolism and behavior. 
Regional Cerebral Blood Flow (rCBF)
Regional cerebral blood flow is strongly related to
regional brain metabolism and regional neural activity
(Leonard et al., 1986; Warwick, 2004). 99mTc-ECD
SPECT, 99mTc-HMPAO SPECT, [15O]-CO2 PET, [15O]-
H2O PET and fMRI are all techniques that reflect the
regional neuronal function.
Neuroimaging studies in human anxiety disorders
have revealed disturbed activity mainly in the medial
prefrontal cortex, the thalamus, the hippocampus and
the amygdala, which are the brain regions involved in
the normal fear circuitry (Figure 3). Most studies de-
scribe a consistently decreased rCBF in the cortical
areas and increased rCBF in the subcortical amygdala
(Bremner, 2004; Etkin and Wager, 2007). Results for
the thalamus and hippocampus are less consistent with
elevated rCBF in obsessive-compulsive disorder
(OCD), but both elevated and decreased rCBF have
been observed in the thalamus of post-traumatic stress
disorder patients (Tillfors et al., 2001; Kent and Rauch,
2003; Lanius et al., 2003; Bremner, 2004; Shin et al.,
2004; Kim et al., 2007). 
Asymmetric changes in rCBF involving mainly the
right amygdala and hippocampus, and accompanied
by altered rCBF in the (ventromedial) prefrontal cor-
tex, are typical for panic disorders (Eren et al., 2003;
van den Heuvel et al., 2005; Lee et al., 2006;
Domschke et al., 2008). Functional MRI studies in ge-
neralized anxiety disorder patients reveal heightened
amygdala activity, which also positively correlates
with the symptom severity, thus revealing that the
amygdala and the prefrontal cortex play an even
greater role. In addition, right amygdala and right
ventrolateral prefrontal cortex activation exhibit a ne-
gative connectivity during the presentation of angry
faces (Monk et al., 2006; Monk et al., 2008). More-
over, other activation fMRI studies in social anxiety
disorder, panic disorder and post-traumatic stress dis-
order also show greater activation of the right
amygdala (van den Heuvel et al., 2005; Etkin and Wa-
ger, 2007; Domschke et al., 2008; Stein and Stein,
2008). A recent canine study found decreased rCBF in
the left frontal cortex, combined with decreased rCBF
in the subcortical area (including the thalamus) and in-
creased rCBF in the temporal cortex (including the
amygdala and hippocampus) of dogs with an anxiety
disorder (Vermeire et al., 2009a). 
Overall, both canine and human neuroimaging
studies confirm the hypothesis of failure of the pre-
frontal cortex to deliver an appropriate response, and
of hyper-responsiveness of the elementary and more
primitive amygdaloid danger recognition system. A
top-down disinhibition involving the absence of com-
pensatory modulation by the prefrontal cortex, leading
to hyperactive amygdalar response, could explain the
underlying mechanism (Kent and Rauch, 2003). 
Serotonin (5-HT)
Concerning affective disorders, it has been shown
that especially the 5-HT2A receptor is of great impor-
tance (Frokjaer et al., 2008). Decreased frontal 5-
HT2A receptor bindings were observed in deliberate
self-harm (Audenaert et al., 2001) and depressed pa-
tients (Biver et al., 1997; Messa et al., 2003), and si-
milar results were found in dogs with anxiety dis-
orders (Vermeire et al., 2009b). Decreased frontal
5-HT2A receptor bindings were also noted in humans
and dogs with (obsessive) compulsive behavior (Perani
et al., 2008; Vermeire et al., 2010). In another human
[18F]-alteserin PET study, significantly higher striatal 5-
HT2A receptor bindings were observed in the striatum
of drug-free OCD patients, and this was interpreted as
a 5-HT2A receptor up-regulation compensation for a
lack of serotonin in the cortico-striatal-thalamic-corti-
cal loops (Adams et al., 2005).
In addition to the 5-HT2A receptor disturbances,
evidence shows disturbed serotonin 1A receptor and se-
rotonin transporter (SERT) densities in both human and
canine anxiety studies. Using PET and [11C]WAY-
100635, different studies have shown both increased
and decreased 5-HT1A receptor binding in the raphe
nuclei in depressed patients (Parsey et al., 2006; Dre-
vets et al., 2007; Sullivan et al., 2009), and 5-HT1A re-
ceptor binding in multiple (para)limbic areas of indi-
viduals with social anxiety disorder, including the
amygdala (Lanzenberger et al., 2007). One study, using
PET, described reduced 5-HT1A receptor binding in
the cingulated and raphe nuclei in patients with panic
disorder (Neumeister et al., 2004). 
SERT binding indices were lower in dogs with
compulsive behavior (Vermeire et al., 2010) and in hu-
man OCD patients (Hesse et al., 2005; Zitterl et al.,
2007; Reimold et al., 2007), as well as in human pa-
tients with panic disorder (Maron et al., 2004), but in-
Figure 3. Transverse slice of the canine brain. (B.O.:
bulbus olfactorius; F.C.: frontal cortex; T.C.: temporal
cortex; C: cerebellum; S: striatum; T: thalamus; Hi:
hippocampus).
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creased in humans with general anxiety disorder (van
der Wee et al., 2008), thus showing that symptomatic
differences (e.g. obsessive-compulsive versus genera-
lized anxiety disorder) can be associated with different
underlying neuro-pathologies.
Dopamine
By comparing drug-naive OCD patients with con-
trols using SPECT [123I]-β-CIT, a significantly reduced
availability of striatal dopamine transporters (DATs)
was found in the OCD patients (Hesse et al., 2005). By
contrast, another study, also using drug-naive OCD
patients and the same radiopharmaceutical, found in-
creased striatal DAT binding (van der Wee et al., 2004).
Altered DAT availability was also noted in generalized
anxiety disorder patients (increased) (van der Wee et
al., 2008) and in social anxiety disorder patients (de-
creased) (Tiihonen et al., 1997a). A recent canine study
observed both increased and decreased DAT densities
in a group of compulsively behaving dogs (Vermeire et
al., 2010).
Imaging of the dopamine system is also feasible
using (semi)-quantifying dopamine receptors. With
this approach, low levels of striatal D1 receptors have
been observed using PET [11C]-SCH23390, a dopamine
D1 receptor antagonist, in drug free (but not all drug
naive) OCD patients (Olver et al., 2008). Low levels of
striatal D2 receptor binding have been observed in
OCD patients using [123I]-iodobenzamide (IBZM) (De-
nys et al., 2004; Schneier et al., 2008) and [11C]-ra-
clopride (Perani et al., 2008), and also in (generalized)
social anxiety disorder patients using [123I]-IBZM
(Schneier et al., 2000; Schneier et al., 2008). The fin-
ding of downregulation of both D2 and D2 receptors in
the striatum suggests increased nigrostriatal dopami-
nergic drive in OCD and social phobia patients.
Gamma Aminobutyric Acid (GABA)
Overall decreased GABAA receptor bindings have
been noted in different anxiety disorders, with the
highest reduction of frontal and temporal cortex in pa-
nic disorder and generalized anxiety disorder (Malizia
et al., 1998; Nutt, 2001; Cameron et al., 2007; Niko-
laus et al., 2010), even though other functional imaging
studies have found no alterations or even increased bin-
ding indices (Nikolaus et al., 2009). 
Several GABAA receptor subtypes (so-called ben-
zodiazepine receptors) are targets of benzodiazepines,
which enhance the postsynaptic phasic inhibition and
consecutively result in an anxiolytic effect. Different
neuroimaging studies have indicated a reduction in
GABA levels and GABAA –benzodiazepine receptor
binding, which can be interpreted as a decrement of the
inhibitory GABAergic input in patients with panic dis-
orders, posttraumatic stress disorder and generalized
anxiety disorder (Tiihonen et al., 1997b; Bremner et al.,
2000a; Bremner et al., 2000b; Goddard et al., 2001;
Nutt, 2001). 
Norepinephrine and glutamate
Up to now neither PET nor SPECT radiopharma-
ceuticals are commercially available for imaging brain
glutamate receptors such as the N-Methyl D-aspartate
(NMDA) receptor subtype or adrenoceptors, and deve-
lopment is still ongoing (Sobrio et al., 2010). A few
anecdotal functional imaging studies exist on the no-
radrenergic system using experimental radioligands.
For instance, Meana et al. noted increased density and
affinity of α2-adrenoreceptor in the hypothalamus and,
to a lesser extent, in the frontal cortex of depressed sui-
cidal patients (Meana et al., 1992). 
Hypothalamic-Pituitary-Adrenal (HPA) Axis
No radiopharmaceuticals exist for imaging corti-
cotropin releasing factor, adrenocorticotropin-relea-
sing hormone or glucocorticoids such as cortisol. How-
ever, by combining rCBF PET imaging and salivary
cortisol measurements in social anxiety disorder pa-
tients performing a public speaking task, a positive cor-
relation between hypothalamic rCBF and salivary cor-
tisol was observed, in addition to a negative correlation
between medial prefrontal cortex and salivary cortisol
(Ahs et al., 2006). Such results indicate that stress-in-
duced cortisol excretion appears to be enhanced by ac-
tivation of the hypothalamus and inhibited by medial
prefrontal cortex activation. 
CONCLUSION
Functional imaging enables in-vivo visualization and
(semi)quantification of multiple brain neurotransmit-
ters. A review of the literature on the functional imaging
of anxiety disorders in humans and canines reveals ma-
jor alterations in the regional cerebral brain perfusion,
the serotonergic system and the dopaminergic system.
Furthermore, the fact that important analogies exist be-
tween humans and dogs regarding these alterations sug-
gests that research in dogs with anxiety disorders can
also be of use in human psychiatry.
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ZEER MODERNE MAATREGELEN TEGEN PAARDENSNOT IN 1746
Oorlogen brachten in het verleden steeds grote concentraties paarden en vee in beweging, met steevast geweldige
uitbraken van besmettelijke ziekten tot gevolg. Toen de Franse legers in 1746 tijdens de Oostenrijkse successieoorlog
weer eens ‘op bezoek’ kwamen in onze streken, werden de militaire paarden (al of niet opgeëist, m.a.w. gestolen bij de
burgers) aangetast door de gevreesde snotziekte. Vermoedelijk was dat droes verwekt door Streptococcus equi infec-
tie al of niet in combinatie met virale luchtwegeninfecties.
Maatregelen werden genomen door de Franse militaire overheid in de veroverde gebieden van Vlaanderen en Bra-
bant. Alle eigenaars van stallen waarin zieke dieren hadden verbleven, werden verplicht dat aan te geven bij de dorps-
schepenen. Deze laatsten moesten lijsten met besmette stallen overhandigen aan de Fransen en aanplakbrieven laten
ophangen met de tekst Stal besmet met de quale vande snotte.
Verder werd bevolen binnen de vijftien dagen de kribben en ruiven te verbranden in aanwezigheid van een wet-
houder. Nog belangrijker en verrassend modern aandoend is het bevel de vloeren (waarschijnlijk de muren: ‘surfaces’
vertaald als ‘vloeren’?) driemaal te witten met ongebluste kalk. Blijkbaar was men in militaire kringen op de hoogte
van het ontsmettende vermogen van dat product lang voor de introductie van desinfectie in de humane verloskunde en
chirurgie door Semmelweiss en Lister en de ontdekkingen van Pasteur en Koch. Uit die tijd stamt de gewoonte kazer-
nemuren te kalken en stallen te witten.
De methode aangewend om deze bevelen te doen opvolgen was ook niet mis. De opbrengst van de zeer zware boete
(meer dan een half jaarloon in het bouwvak uit die tijd) bij overtredingen mocht namelijk voor de helft te goede komen
aan de armen van het dorp en voor de andere helft aan de aanbrenger!
Bron: Nederlandstalig afschrift van deze maatregelen opgenomen in het ‘Boek der Voorgeboden’ van de stad Gent
(Stadsarchief Gent, reeks 108 nr. 7, folio 104 recto - folio 105 verso).
Luc Devriese
